id="u25f75136-8bdc-5c02-b0cd-0a8cf19c61b8">
Table of Contents
1 Cover
6 Preface
7 1 What Do APRN Prescribers Need to Understand? THE JOURNEY OF APRN PRESCRIPTIVE AUTHORITY OVERVIEW OF CHAPTERS CONCLUSION REFERENCES
8 2 Embracing the PrescriberRole as an APRN DEVELOPMENT OF THE APRN ROLE DEVELOPMENT OF THE APRN ROLE AND PRESCRIPTIVE AUTHORITY ADAPTING TO THE APRN’S ROLE AS PRESCRIBER BARRIERS TO TRANSITIONING TO THE PRESCRIBER ROLE A FRAMEWORK FOR PRESCRIBING SPECIAL CONSIDERATIONS FOR PRESCRIBING THE FUTURE OF THE APRN PRESCRIBING ROLE REFERENCES
9 3 Creating a Practice Environmentfor Full Prescriptive Authority EXTERNAL BARRIERS TO PRESCRIBING INTERNAL BARRIERS TO PRESCRIBING STRATEGIES TO ADDRESS PRESCRIBING BARRIERS ELIMINATING EXTERNAL BARRIERS TO PRESCRIBING ELIMINATING INTERNAL BARRIERS TO PRESCRIBING IMPLICATIONS REFERENCES
10 4 Regulation of PrescriptiveAuthority A MODEL FOR APRN FULL PRACTICE AUTHORITY CONSENSUS MODEL FOR APRN REGULATION HISTORY OF APRN PRESCRIBING REGULATION AUTONOMOUS PRESCRIPTIVE AUTHORITY OTHER REGULATORY REQUIREMENTS PRESCRIPTIVE AUTHORITY LIMITATIONS CONCLUSION REFERENCES
11 5 Global Prescribing DEFINING THE ADVANCED PRACTICE NURSE GLOBALLY COUNTRIES WITH ADVANCED PRACTICE ROLES TASK SHARING NURSE PRESCRIBING OUTCOMES OF NURSE PRESCRIBING APRN PRESCRIBING CONCLUSION REFERENCES
12 6 Managing Difficult andComplex Patient Interactions KNOWLEDGE OF SELF AS THE FOUNDATION FOR PROFESSIONAL GROWTH MOTIVATIONAL INTERVIEWING AS THE FOUNDATION FOR COUNSELING ABOUT CHANGE ETHICAL CONSIDERATIONS WHEN DEALING WITH DIFFICULT AND COMPLEX PATIENT INTERACTIONS ENGAGING PATIENTS WITH SUBSTANCE‐RELATED CONCERNS THE OPIOID EPIDEMIC AS A PROMPT FOR DIFFICULT CONVERSATIONS MANAGING INTERACTIONS THAT CAN LEAD TO BOUNDARY VIOLATIONS ENGAGING PATIENTS WITH BEHAVIORAL HEALTH ISSUES SOMATIC SYMPTOMS AND RELATED DISORDERS RESPONDING TO A REQUEST FOR INAPPROPRIATE TREATMENT PATIENT ISSUES ABOUT THEIR TREATMENT RECOMMENDATIONS CONCLUSION REFERENCES
13 7 Practical Considerations when Prescribing Controlled Substances DEFINITIONS RELATED TO CONTROLLED SUBSTANCES THE OPIOID EPIDEMIC BEST PRACTICES WHEN PRESCRIBING CONTROLLED SUBSTANCES CLINICAL GUIDELINES AND CONSENSUS STATEMENTS CLINICAL GUIDANCE FOR BENZODIAZEPINES AND OTHER CONTROLLED SUBSTANCES ASSESSMENT
